SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-010844
Filing Date
2022-02-02
Accepted
2022-02-02 16:12:40
Documents
12
Period of Report
2022-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm225152d1_8k.htm   iXBRL 8-K 27497
  Complete submission text file 0001104659-22-010844.txt   200618

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20220128.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20220128_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20220128_pre.xml EX-101.PRE 22597
6 EXTRACTED XBRL INSTANCE DOCUMENT tm225152d1_8k_htm.xml XML 3612
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 22583752
SIC: 2834 Pharmaceutical Preparations